{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:05:58Z","timestamp":1792292758278,"version":"4.4.0"},"reference-count":174,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Path"],"published-print":{"date-parts":[[1998,12]]},"DOI":"10.1136\/mp.51.6.293","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T19:10:34Z","timestamp":1230750634000},"page":"293-304","source":"Crossref","is-referenced-by-count":43,"title":["Genetic risk factors in Alzheimer's disease."],"prefix":"10.1136","volume":"51","author":[{"given":"L","family":"Tilley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kalsheker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1998,12,1]]},"reference":[{"key":"ref_1","first-page":"146","article-title":"Uber Eine Eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer, A.","year":"1907","unstructured":"Alzheimer A. Uber Eine Eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift fur Psychiatrie 1907;64:146\u20138.","journal-title":"Allgemeine Zeitschrift fur Psychiatrie"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.410300310","article-title":"Frequency and distribution of Alzheimer\u2019s-disease in Europe\u2014a collaborative study of 1980\u20131990 prevalence findings","volume":"30","author":"Rocca, W.A.; Hofman, A.; Brayne, C.","year":"1991","unstructured":"Rocca WA, Hofman A, Brayne C, et al. Frequency and distribution of Alzheimer\u2019s-disease in Europe\u2014a collaborative study of 1980\u20131990 prevalence findings. Ann Neurol 1991; 30:381\u201390.","journal-title":"Ann Neurol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-113-6-429","article-title":"Survival of outpatients with Alzheimer-type dementia","volume":"113","author":"Walsh, J.S.; Welch, H.G.; Larson, E.B.","year":"1990","unstructured":"Walsh JS, Welch HG, Larson EB. Survival of outpatients with Alzheimer-type dementia. Ann Intern Med 1990;113: 429\u201334.","journal-title":"Ann Intern Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0166-2236(93)90078-Z","article-title":"Tau-protein and the neurofibrillary pathology of Alzheimer\u2019s-disease","volume":"16","author":"Goedert, M.","year":"1993","unstructured":"Goedert M. Tau-protein and the neurofibrillary pathology of Alzheimer\u2019s-disease. Trends Neurosci 1993;16:460\u20135.","journal-title":"Trends Neurosci"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s-disease\u2014initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner, G.G.; Wong, C.W.","year":"1984","unstructured":"Glenner GG, Wong CW. Alzheimer\u2019s-disease\u2014initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885\u201390.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the beta-amyloid protein is critical for the seeding of amyloid formation\u2014implications for the pathogenesis of Alzheimer\u2019s-disease","volume":"32","author":"Jarrett, J.T.; Berger, E.P.; Lansbury, P.T.","year":"1993","unstructured":"Jarrett JT, Berger EP, Lansbury PT. The carboxy terminus of the beta-amyloid protein is critical for the seeding of amyloid formation\u2014implications for the pathogenesis of Alzheimer\u2019s-disease. Biochemistry 1993;32:4693\u20137.","journal-title":"Biochemistry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","article-title":"The precursor of Alzheimer\u2019s-disease amyloid-A4 protein resembles a cellsurface receptor","volume":"325","author":"Kang, J.; Lemaire, H.G.; Unterbeck, A.","year":"1987","unstructured":"Kang J, Lemaire HG, Unterbeck A, et al. The precursor of Alzheimer\u2019s-disease amyloid-A4 protein resembles a cellsurface receptor. Nature 1987;325:733\u20136.","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.2949367","article-title":"Amyloid beta-protein gene\u2014cDNA, messenger-RNA distribution, and genetic-linkage near the Alzheimer locus","volume":"235","author":"Tanzi, R.E.; Gusella, J.F.; Watkins, P.C.","year":"1987","unstructured":"Tanzi RE, Gusella JF, Watkins PC, et al. Amyloid beta-protein gene\u2014cDNA, messenger-RNA distribution, and genetic-linkage near the Alzheimer locus. Science 1987; 235:880\u20134.","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0092-8674(88)90462-X","article-title":"Immunochemical identification of the serine protease inhibitor alpha-1antichymotrypsin in the brain amyloid deposits of Alzheimer\u2019s-disease","volume":"52","author":"Abraham, C.R.; Selkoe, D.J.; Potter, H.","year":"1988","unstructured":"Abraham CR, Selkoe DJ, Potter H. Immunochemical identification of the serine protease inhibitor alpha-1antichymotrypsin in the brain amyloid deposits of Alzheimer\u2019s-disease. Cell 1988;52:487\u2013501.","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF00294446","article-title":"Distribution pattern and functional-state of alpha-1-antichymotrypsin in plaques and vascular amyloid in Alzheimer\u2019sdisease\u2014an immunohistochemical study with monoclonalantibodies against native and inactivated alpha-1antichymotrypsin","volume":"82","author":"Rozemuller, J.M.; Abbink, J.J.; Kamp, A.M.","year":"1991","unstructured":"Rozemuller JM, Abbink JJ, Kamp AM, et al. Distribution pattern and functional-state of alpha-1-antichymotrypsin in plaques and vascular amyloid in Alzheimer\u2019sdisease\u2014an immunohistochemical study with monoclonalantibodies against native and inactivated alpha-1antichymotrypsin. Acta Neuropathol 1991;82:200\u20137.","journal-title":"Acta Neuropathol"},{"key":"ref_11","first-page":"247","article-title":"Alpha-1antichymotrypsin is present in diVuse senile plaques\u2014a comparative-study of beta-protein and alpha-1- antichymotrypsin immunostaining in the Alzheimer brain","volume":"138","author":"Shoji, M.; Hirai, S.; Yamaguchi, H.","year":"1991","unstructured":"Shoji M, Hirai S, Yamaguchi H, et al. Alpha-1antichymotrypsin is present in diVuse senile plaques\u2014a comparative-study of beta-protein and alpha-1- antichymotrypsin immunostaining in the Alzheimer brain. Am J Pathol 1991;138:247\u201357.","journal-title":"Am J Pathol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","article-title":"Apolipoprotein-E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s-disease and kuru plaque amyloid in Creutzfeldt-Jakob disease","volume":"541","author":"Namba, Y.; Tomonaga, M.; Kawasaki, H.","year":"1991","unstructured":"Namba Y, Tomonaga M, Kawasaki H, et al. Apolipoprotein-E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s-disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541:163\u20136.","journal-title":"Brain Res"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.1899488","article-title":"A68\u2014a major subunit of paired helical filaments and derivatized forms of normaltau","volume":"251","author":"Lee, V.M.Y.; Balin, B.J.; Otvos, L.","year":"1991","unstructured":"Lee VMY, Balin BJ, Otvos L, et al. A68\u2014a major subunit of paired helical filaments and derivatized forms of normaltau. Science 1991;251:675\u20138.","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0896-6273(93)90063-W","article-title":"Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments","volume":"10","author":"Morishima-Kawashima, M.; Hasegawa, M.; Takio, K.","year":"1993","unstructured":"Morishima-Kawashima M, Hasegawa M, Takio K, et al. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 1993;10:1151\u201360.","journal-title":"Neuron"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(96)91272-6","article-title":"Alzheimer\u2019s-disease in Finnish twins","volume":"347","author":"Raiha, I.; Kaprio, J.; Koskenvuo, M.","year":"1996","unstructured":"Raiha I, Kaprio J, Koskenvuo M, et al. Alzheimer\u2019s-disease in Finnish twins. Lancet 1996;347:573\u20138.","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.37.3.359","article-title":"Dementia of the Alzheimer type\u2014clinical and family study of 22 twin pairs","volume":"37","author":"Nee, L.E.; Eldridge, R.; Sunderland, T.","year":"1987","unstructured":"Nee LE, Eldridge R, Sunderland T, et al. Dementia of the Alzheimer type\u2014clinical and family study of 22 twin pairs. Neurology 1987;37:359\u201363.","journal-title":"Neurology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ije\/20.Supplement_2.S4","article-title":"Risk-factors for Alzheimers-disease\u2014overview of the Eurodem collaborative reanalysis of case-control studies","volume":"20","author":"VanDuijn, C.M.; Stijnen, T.; Hofman, A.","year":"1991","unstructured":"VanDuijn CM, Stijnen T, Hofman A. Risk-factors for Alzheimers-disease\u2014overview of the Eurodem collaborative reanalysis of case-control studies. Int J Epidemiol 1991; 20:S4\u201312.","journal-title":"Int J Epidemiol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s-disease","volume":"349","author":"Goate, A.; Chartierharlin, M.C.; Mullan, M.","year":"1991","unstructured":"Goate A, Chartierharlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s-disease. Nature 1991;349: 704\u20136.","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/353844a0","article-title":"Earlyonset Alzheimer\u2019s disease caused by mutations at codon 717 of the B-amyloid precursor protein gene","volume":"353","author":"Chartier-Harlin, M.-C.; Crawford, F.; Houlden, H.","year":"1991","unstructured":"Chartier-Harlin M-C, Crawford F, Houlden H, et al. Earlyonset Alzheimer\u2019s disease caused by mutations at codon 717 of the B-amyloid precursor protein gene. Nature 1991; 353:844\u20136.","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","article-title":"A pathogenic mutation for probable Alzheimer\u2019s-disease in the APP gene at the N-terminus of beta-amyloid","volume":"1","author":"Mullan, M.; Crawford, F.; Axelman, K.","year":"1992","unstructured":"Mullan M, Crawford F, Axelman K, et al. A pathogenic mutation for probable Alzheimer\u2019s-disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1992;1:345\u2013 7.","journal-title":"Nat Genet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1925564","article-title":"A mutation in the amyloid precursor protein associated with hereditary Alzheimer\u2019s-disease","volume":"254","author":"Murrell, J.; Farlow, M.; Ghetti, B.","year":"1991","unstructured":"Murrell J, Farlow M, Ghetti B, et al. A mutation in the amyloid precursor protein associated with hereditary Alzheimer\u2019s-disease. Science 1991;254:97\u20139.","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ng0692-218","article-title":"Presenile-dementia and cerebral-hemorrhage linked to a mutation at codon- 692 of the beta-amyloid precursor protein gene","volume":"1","author":"Hendriks, L.; Vanduijn, C.M.; Cras, P.","year":"1992","unstructured":"Hendriks L, Vanduijn CM, Cras P, et al. Presenile-dementia and cerebral-hemorrhage linked to a mutation at codon- 692 of the beta-amyloid precursor protein gene. Nat Genet 1992;1:218\u201321.","journal-title":"Nat Genet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.2111584","article-title":"Mutation of the Alzheimer\u2019s-disease amyloid gene in hereditary cerebralhemorrhage, Dutch type","volume":"248","author":"Levy, E.; Carman, M.D.; Fernandezmadrid, I.J.","year":"1990","unstructured":"Levy E, Carman MD, Fernandezmadrid IJ, et al. Mutation of the Alzheimer\u2019s-disease amyloid gene in hereditary cerebralhemorrhage, Dutch type. Science 1990;248:1124\u20136.","journal-title":"Science"},{"key":"ref_24","first-page":"9","article-title":"Molecular genetics of Alzheimer\u2019s disease","volume":"52","author":"Goate, A.M.","year":"1997","unstructured":"Goate AM. Molecular genetics of Alzheimer\u2019s disease. Geriatrics 1997;52:S9\u201317.","journal-title":"Geriatrics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng1292-335","article-title":"Mapping of a gene predisposing to early-onset Alzheimer\u2019sdisease to chromosome 14q24.3","volume":"2","author":"C, Van Broeckhoven; H, Backhovens; M, Cruts","year":"1992","unstructured":"Van Broeckhoven C, Backhovens H, Cruts M, et al. Mapping of a gene predisposing to early-onset Alzheimer\u2019sdisease to chromosome 14q24.3. Nat Genet 1992;2:335\u20139.","journal-title":"Nat Genet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.1411576","article-title":"Geneticlinkage evidence for a familial Alzheimer\u2019s-disease locus on chromosome-14","volume":"258","author":"Schellenberg, G.D.; Bird, T.D.; Wijsman, E.M.","year":"1992","unstructured":"Schellenberg GD, Bird TD, Wijsman EM, et al. Geneticlinkage evidence for a familial Alzheimer\u2019s-disease locus on chromosome-14. Science 1992;258:668\u201371.","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng1292-330","article-title":"Geneticevidence for a novel familial Alzheimer\u2019s-disease locus on chromosome-14","volume":"2","author":"P, St George Hyslop; J, Haines; E, Rogaev","year":"1992","unstructured":"St George Hyslop P, Haines J, Rogaev E, et al. Geneticevidence for a novel familial Alzheimer\u2019s-disease locus on chromosome-14. Nat Genet 1992;2:330\u20134.","journal-title":"Nat Genet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1097\/00001756-199607080-00009","article-title":"A novel presenilin-1 mutation resulting in familial Alzheimer\u2019sdisease with an onset age of 29 years","volume":"7","author":"Campion, D.; Brice, A.; Dumanchin, C.","year":"1996","unstructured":"Campion D, Brice A, Dumanchin C, et al. A novel presenilin-1 mutation resulting in familial Alzheimer\u2019sdisease with an onset age of 29 years. Neuroreport 1996;7:1582\u20134.","journal-title":"Neuroreport"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00001756-199512000-00071","article-title":"A mutation in Alzheimer\u2019s-disease destroying a splice acceptor site in the presenilin-1 gene","volume":"7","author":"Perez-Tur, J.; Froelich, S.; Prihar, G.","year":"1995","unstructured":"Perez-Tur J, Froelich S, Prihar G, et al. A mutation in Alzheimer\u2019s-disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 1995;7:297\u2013301.","journal-title":"Neuroreport"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/ng1195-230","article-title":"Presenilins and Alzheimer-disease","volume":"11","author":"C, Van Broeckhoven","year":"1995","unstructured":"Van Broeckhoven C. Presenilins and Alzheimer-disease. Nat Genet 1995;11:230\u20132.","journal-title":"Nat Genet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/377351a0","article-title":"Facilitation of lin-12-mediated signaling by Sel-12, a Caenorhabditis-elegans S182 Alzheimer\u2019s-disease gene","volume":"377","author":"Levitan, D.; Greenwald, I.","year":"1995","unstructured":"Levitan D, Greenwald I. Facilitation of lin-12-mediated signaling by Sel-12, a Caenorhabditis-elegans S182 Alzheimer\u2019s-disease gene. Nature 1995;377:351\u20134.","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/387288a0","article-title":"Presenilin 1 is required for Notch1 DII1 expression in the paraxial mesoderm","volume":"387","author":"Wong, P.C.; Zheng, H.; Chen, H.","year":"1997","unstructured":"Wong PC, Zheng H, Chen H, et al. Presenilin 1 is required for Notch1 DII1 expression in the paraxial mesoderm. Nature 1997;387:288\u201392.","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0092-8674(00)80244-5","article-title":"Skeletal and CNS defects in presenilin-1-deficient mice","volume":"89","author":"Shen, J.; Bronson, R.T.; Chen, D.F.","year":"1997","unstructured":"Shen J, Bronson RT, Chen DF, et al. Skeletal and CNS defects in presenilin-1-deficient mice. Cell 1997;89:629\u2013 39.","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.7638621","article-title":"A familial Alzheimer\u2019s-disease locus on chromosome-1","volume":"269","author":"Levy-Lahad, E.; Wijsman, E.M.; Nemens, E.","year":"1995","unstructured":"Levy-Lahad E, Wijsman EM, Nemens E, et al. A familial Alzheimer\u2019s-disease locus on chromosome-1. Science 1995; 269:970\u20133.","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome-1 familial Alzheimer\u2019s-disease locus","volume":"269","author":"Levy-Lahad, E.; Wasco, W.; Poorkaj, P.","year":"1995","unstructured":"Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome-1 familial Alzheimer\u2019s-disease locus. Science 1995;269:973\u20137.","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/383710a0","article-title":"Increased amyloid-beta- 42(43) in brains of mice expressing mutant presenilin-1","volume":"383","author":"DuV, K.; Eckman, C.; Zehr, C.","year":"1996","unstructured":"DuV K, Eckman C, Zehr C, et al. Increased amyloid-beta- 42(43) in brains of mice expressing mutant presenilin-1. Nature 1996;383:710\u20133.","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s-disease is increased in-vivo by the presenilin-1 and presenilin-2 and APP mutations linked to familial Alzheimer\u2019s-disease","volume":"2","author":"Scheuner, D.; Eckman, C.; Jensen, M.","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s-disease is increased in-vivo by the presenilin-1 and presenilin-2 and APP mutations linked to familial Alzheimer\u2019s-disease. Nat Med 1996;2:864\u201370.","journal-title":"Nat Med"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm0197-67","article-title":"Mutant presenilins of Alzheimer\u2019s disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice","volume":"3","author":"Citron, M.; Westaway, D.; Xia, W.M.","year":"1997","unstructured":"Citron M, Westaway D, Xia WM, et al. Mutant presenilins of Alzheimer\u2019s disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 1997;3:67\u201372.","journal-title":"Nat Med"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nm0797-756","article-title":"Hyperaccumulation of FAD-linked presenilin 1 variants in vivo","volume":"3","author":"Lee, M.K.; Borchelt, D.R.; Kim, G.","year":"1997","unstructured":"Lee MK, Borchelt DR, Kim G, et al. Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. Nat Med 1997;3: 756\u201360.","journal-title":"Nat Med"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/01677068709167221","article-title":"Association of an apolipoprotein-CII allele with familial dementia of the Alzheimer type","volume":"4","author":"Schellenberg, G.D.; Deeb, S.S.; Boehnke, M.","year":"1987","unstructured":"Schellenberg GD, Deeb SS, Boehnke M, et al. Association of an apolipoprotein-CII allele with familial dementia of the Alzheimer type. J Neurogenet 1987;4:97\u2013108.","journal-title":"J Neurogenet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.410310214","article-title":"Genetic association and linkage analysis of the apolipoprotein-CII locus and familial Alzheimer\u2019s-disease","volume":"31","author":"Schellenberg, G.D.; Boehnke, M.; Wijsman, E.M.","year":"1992","unstructured":"Schellenberg GD, Boehnke M, Wijsman EM, et al. Genetic association and linkage analysis of the apolipoprotein-CII locus and familial Alzheimer\u2019s-disease. Ann Neurol 1992; 31:223\u20137.","journal-title":"Ann Neurol"},{"key":"ref_42","first-page":"1034","article-title":"Linkage studies in familial Alzheimer-disease\u2014evidence for chromosome-19 linkage","volume":"48","author":"Pericak-Vance, M.A.; Bebout, J.L.; Gaskell, P.C.","year":"1991","unstructured":"Pericak-Vance MA, Bebout JL, Gaskell PC, et al. Linkage studies in familial Alzheimer-disease\u2014evidence for chromosome-19 linkage. Am J Hum Genet 1991;48:1034\u2013 50.","journal-title":"Am J Hum Genet"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein-E type-4 allele and the risk of Alzheimer\u2019s-disease in late-onset families","volume":"261","author":"Corder, E.H.; Saunders, A.M.; Strittmatter, W.J.","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein-E type-4 allele and the risk of Alzheimer\u2019s-disease in late-onset families. Science 1993; 261:921\u20133.","journal-title":"Science"},{"key":"ref_44","first-page":"192","article-title":"Association of apolipoprotein-E allele-E4 with late-onset familial and sporadic Alzheimer\u2019s-disease","volume":"43","author":"Roses, A.D.; Saunders, A.M.; Strittmatter, W.J.","year":"1993","unstructured":"Roses AD, Saunders AM, Strittmatter WJ, et al. Association of apolipoprotein-E allele-E4 with late-onset familial and sporadic Alzheimer\u2019s-disease. Neurology 1993;43:A192.","journal-title":"Neurology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein-E allele epsilon-4 with late-onset familial and sporadic Alzheimer\u2019s-disease","volume":"43","author":"Saunders, A.M.; Strittmatter, W.J.; Schmechel, D.","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein-E allele epsilon-4 with late-onset familial and sporadic Alzheimer\u2019s-disease. Neurology 1993; 43:1467\u201372.","journal-title":"Neurology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/hmg\/3.4.569","article-title":"Apolipoprotein-E, epsilon-4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer\u2019sdisease\u2014analysis of the 19q13.2 chromosomal region","volume":"3","author":"Chartier-Harlin, M.C.; Parfitt, M.; Legrain, S.","year":"1994","unstructured":"Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipoprotein-E, epsilon-4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer\u2019sdisease\u2014analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994;3:569\u201374.","journal-title":"Hum Mol Genet"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ng0594-10b","article-title":"ApoE-epsilon-4 and early-onset Alzheimers","volume":"7","author":"Okuizumi, K.; Onodera, O.; Tanaka, H.","year":"1994","unstructured":"Okuizumi K, Onodera O, Tanaka H, et al. ApoE-epsilon-4 and early-onset Alzheimers. Nat Genet 1994;7:10\u20131.","journal-title":"Nat Genet"},{"key":"ref_48","first-page":"697","volume":"342","author":"Poirier, J.; Davignon, J.; Bouthillier, D.","year":"1993","unstructured":"Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein-E polymorphism and Alzheimer\u2019s-disease. Lancet 1993;342: 697\u20139.","journal-title":"Apolipoprotein-E polymorphism and Alzheimer\u2019s-disease. Lancet"},{"key":"ref_49","first-page":"643","article-title":"ApolipoproteinE\u2014risk factor for Alzheimer-disease","volume":"54","author":"Tsai, M.S.; Tangalos, E.G.; Petersen, R.C.","year":"1994","unstructured":"Tsai MS, Tangalos EG, Petersen RC, et al. ApolipoproteinE\u2014risk factor for Alzheimer-disease. Am J Hum Genet 1994;54:643\u20139.","journal-title":"Am J Hum Genet"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/jama.1994.03510410028015","article-title":"Alzheimer\u2019s-disease, apolipoprotein E4, and gender","volume":"271","author":"Payami, H.; Montee, K.R.; Kaye, J.A.","year":"1994","unstructured":"Payami H, Montee KR, Kaye JA, et al. Alzheimer\u2019s-disease, apolipoprotein E4, and gender. JAMA 1994;271:1316\u201317.","journal-title":"JAMA"},{"key":"ref_51","first-page":"803","article-title":"Gender difference in apolipoprotein E-associated risk for familial Alzheimerdisease\u2014a possible clue to the higher incidence of Alzheimer-disease in women","volume":"58","author":"Payami, H.; Zareparsi, S.; Montee, K.R.","year":"1996","unstructured":"Payami H, Zareparsi S, Montee KR, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimerdisease\u2014a possible clue to the higher incidence of Alzheimer-disease in women. Am J Hum Genet 1996;58: 803\u201311.","journal-title":"Am J Hum Genet"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jama.1995.03520290025013","article-title":"The apolipoprotein-E E4 allele and sex-specific risk of Alzheimer\u2019s-disease","volume":"273","author":"Corder, E.H.; Saunders, A.M.; Strittmatter, W.J.","year":"1995","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, et al. The apolipoprotein-E E4 allele and sex-specific risk of Alzheimer\u2019s-disease. JAMA 1995;273:373\u20134.","journal-title":"JAMA"},{"key":"ref_53","first-page":"439","article-title":"Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex","volume":"60","author":"Bickeboller, H.; Campion, D.; Brice, A.","year":"1997","unstructured":"Bickeboller H, Campion D, Brice A, et al. Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet 1997;60:439\u201346.","journal-title":"Am J Hum Genet"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective eVect of apolipoprotein-E type-2 allele for late-onset Alzheimerdisease","volume":"7","author":"Corder, E.H.; Saunders, A.M.; Risch, N.J.","year":"1994","unstructured":"Corder EH, Saunders AM, Risch NJ, et al. Protective eVect of apolipoprotein-E type-2 allele for late-onset Alzheimerdisease. Nat Genet 1994;7:180\u20134.","journal-title":"Nat Genet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410370217","article-title":"Apolipoprotein-E and Alzheimers-disease\u2014ethnic variation in genotypic risks","volume":"37","author":"Maestre, G.; Ottman, R.; Stern, Y.","year":"1995","unstructured":"Maestre G, Ottman R, Stern Y, et al. Apolipoprotein-E and Alzheimers-disease\u2014ethnic variation in genotypic risks. Ann Neurol 1995;37:254\u20139.","journal-title":"Ann Neurol"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0304-3940(94)90054-X","article-title":"ApoE allele frequencies in Italian sporadic and familial Alzheimer\u2019s-disease","volume":"177","author":"Sorbi, S.; Nacmias, B.; Forleo, P.","year":"1994","unstructured":"Sorbi S, Nacmias B, Forleo P, et al. ApoE allele frequencies in Italian sporadic and familial Alzheimer\u2019s-disease. Neurosci Lett 1994;177:100\u20132.","journal-title":"Neurosci Lett"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ana.410370510","article-title":"The apolipoprotein-E epsilon-2 allele is associated with an increased risk of early-onset Alzheimer\u2019s-disease and a reduced survival","volume":"37","author":"VanDuijn, C.M.; DeknijV, P.; Wehnert, A.","year":"1995","unstructured":"VanDuijn CM, DeknijV P, Wehnert A, et al. The apolipoprotein-E epsilon-2 allele is associated with an increased risk of early-onset Alzheimer\u2019s-disease and a reduced survival. Ann Neurol 1995;37:605\u201310.","journal-title":"Ann Neurol"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/hmg\/7.3.533","article-title":"A new polymorphism in the APOE promoter associated with risk of developing Alzheimer\u2019s disease","volume":"7","author":"Lambert, J.C.; Pasquier, F.; Cottel, D.","year":"1998","unstructured":"Lambert JC, Pasquier F, Cottel D, et al. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer\u2019s disease. Hum Mol Genet 1998;7: 533\u201340.","journal-title":"Hum Mol Genet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ng0198-69","article-title":"A polymorphism in the regulatory region of APOE associated with risk for Alzheimer\u2019s dementia","volume":"18","author":"Bullido, M.J.; Artiga, M.J.; Recuero, M.","year":"1998","unstructured":"Bullido MJ, Artiga MJ, Recuero M, et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer\u2019s dementia. Nat Genet 1998;18:69\u201371.","journal-title":"Nat Genet"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3940(98)00470-4","article-title":"Absence of association between Alzheimer disease and the \u2013491 regulatory region polymorphism of APOE","volume":"250","author":"Song, Y.Q.; Rogaeva, E.; Premkumar, S.","year":"1998","unstructured":"Song YQ, Rogaeva E, Premkumar S, et al. Absence of association between Alzheimer disease and the \u2013491 regulatory region polymorphism of APOE. Neurosci Lett 1998;250:189\u201392.","journal-title":"Neurosci Lett"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","article-title":"Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease","volume":"349","author":"Itzhaki, R.F.; Lin, W.R.; Shang, D.H.","year":"1997","unstructured":"Itzhaki RF, Lin WR, Shang DH, et al. Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease. Lancet 1997;349:241\u20134.","journal-title":"Lancet"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0021-9258(17)42151-X","article-title":"chromosome location, and expression of the human very-low-density lipoprotein receptor gene","volume":"269","author":"Sakai, J.; Hoshino, A.; Takahashi, S.","year":"1994","unstructured":"Sakai J, Hoshino A, Takahashi S, et al. Structure, chromosome location, and expression of the human very-low-density lipoprotein receptor gene. J Biol Chem 1994;269:2173\u201382.","journal-title":"J Biol Chem"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"9252","DOI":"10.1073\/pnas.89.19.9252","article-title":"Rabbit very low-density-lipoprotein receptor\u2014a low-density-lipoprotein receptor-like protein with distinct ligand specificity","volume":"89","author":"Takahashi, S.; Kawarabayasi, Y.; Nakai, T.","year":"1992","unstructured":"Takahashi S, Kawarabayasi Y, Nakai T, et al. Rabbit very low-density-lipoprotein receptor\u2014a low-density-lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 1992;89:9252\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ng1095-207","article-title":"Genetic association of the very-low-density lipoprotein (VLDL) receptor gene with sporadic Alzheimer\u2019s-disease","volume":"11","author":"Okuizumi, K.; Onodera, O.; Namba, Y.","year":"1995","unstructured":"Okuizumi K, Onodera O, Namba Y, et al. Genetic association of the very-low-density lipoprotein (VLDL) receptor gene with sporadic Alzheimer\u2019s-disease. Nat Genet 1995;11:207\u20139.","journal-title":"Nat Genet"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ana.410390617","article-title":"Lack of association of trinucleotide repeat polymorphisms in the very-low-density lipoprotein receptor gene with Alzheimer\u2019s-disease","volume":"39","author":"Chung, H.; Roberts, C.T.; Greenberg, S.","year":"1996","unstructured":"Chung H, Roberts CT, Greenberg S, et al. Lack of association of trinucleotide repeat polymorphisms in the very-low-density lipoprotein receptor gene with Alzheimer\u2019s-disease. Ann Neurol 1996;39:800\u20133.","journal-title":"Ann Neurol"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.410400220","article-title":"Lack of association of very-low-density lipoprotein receptor gene polymorphism with Caucasian Alzheimer\u2019s-disease","volume":"40","author":"Okuizumi, K.; Onodera, O.; Seki, K.","year":"1996","unstructured":"Okuizumi K, Onodera O, Seki K, et al. Lack of association of very-low-density lipoprotein receptor gene polymorphism with Caucasian Alzheimer\u2019s-disease. Ann Neurol 1996;40: 251\u20134.","journal-title":"Ann Neurol"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0304-3940(96)12630-6","article-title":"No association between very-low-density lipoprotein receptor (VLDL-R) and Alzheimer-disease in American Caucasians","volume":"209","author":"Pritchard, M.L.; Saunders, A.M.; Gaskell, P.C.","year":"1996","unstructured":"Pritchard ML, Saunders AM, Gaskell PC, et al. No association between very-low-density lipoprotein receptor (VLDL-R) and Alzheimer-disease in American Caucasians. Neurosci Lett 1996;209:105\u20138.","journal-title":"Neurosci Lett"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(97)13381-X","article-title":"Genetic association studies between dementia of the Alzheimer\u2019s type and three receptors for apolipoprotein E in a Caucasian population","volume":"222","author":"Lendon, C.L.; Talbot, C.J.; Craddock, N.J.","year":"1997","unstructured":"Lendon CL, Talbot CJ, Craddock NJ, et al. Genetic association studies between dementia of the Alzheimer\u2019s type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett 1997;222:187\u201390.","journal-title":"Neurosci Lett"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1098-2272(1997)14:3<299::AID-GEPI7>3.0.CO;2-0","article-title":"No association between the very low density lipoprotein receptor gene and late-onset Alzheimer\u2019s disease nor interaction with the apolipoprotein E gene in population-based and clinic samples","volume":"14","author":"Fallin, D.; Gauntlett, A.C.; Scibelli, P.","year":"1997","unstructured":"Fallin D, Gauntlett AC, Scibelli P, et al. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer\u2019s disease nor interaction with the apolipoprotein E gene in population-based and clinic samples. Genet Epidemiol 1997;14:299\u2013305.","journal-title":"Genet Epidemiol"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/hmg\/3.3.521","article-title":"CGG triple repeat polymorphism in VLDL receptor (VLDL-R) gene","volume":"3","author":"Jokinen, E.; Sakai, J.; Yamamoto, T.","year":"1994","unstructured":"Jokinen E, Sakai J, Yamamoto T, et al. CGG triple repeat polymorphism in VLDL receptor (VLDL-R) gene. Hum Mol Genet 1994;3:521.","journal-title":"Hum Mol Genet"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1212\/WNL.47.5.1349","article-title":"The 5-repeat allele in the very-low-density lipoprotein receptor gene polymorphism is not increased in sporadic Alzheimer\u2019s-disease in Japanese","volume":"47","author":"Arinami, T.; Takekoshi, K.; Yanagi, H.","year":"1996","unstructured":"Arinami T, Takekoshi K, Yanagi H, et al. The 5-repeat allele in the very-low-density lipoprotein receptor gene polymorphism is not increased in sporadic Alzheimer\u2019s-disease in Japanese. Neurology 1996;47:1349\u201350.","journal-title":"Neurology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archneur.1997.00550220087019","article-title":"Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease","volume":"54","author":"Clatworthy, A.E.; GomezIsla, T.; Rebeck, G.W.","year":"1997","unstructured":"Clatworthy AE, GomezIsla T, Rebeck GW, et al. Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease. Arch Neurol 1997;54:1289\u201392.","journal-title":"Arch Neurol"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0304-3940(97)00304-2","article-title":"Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer\u2019s disease","volume":"227","author":"Wavrant-DeVrieze, F.; PerezTur, J.; Lambert, J.C.","year":"1997","unstructured":"Wavrant-DeVrieze F, PerezTur J, Lambert JC, et al. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer\u2019s disease. Neurosci Lett 1997; 227:68\u201370.","journal-title":"Neurosci Lett"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(97)00634-4","article-title":"No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer\u2019s disease in a communitybased sample","volume":"233","author":"Fallin, D.; Kundtz, A.; Town, T.","year":"1997","unstructured":"Fallin D, Kundtz A, Town T, et al. No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer\u2019s disease in a communitybased sample. Neurosci Lett 1997;233:145\u20137.","journal-title":"Neurosci Lett"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/WNL.49.1.56","article-title":"Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer\u2019s disease","volume":"49","author":"Kang, D.E.; Saitoh, T.; Chen, X.","year":"1997","unstructured":"Kang DE, Saitoh T, Chen X, et al. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer\u2019s disease. Neurology 1997;49:56\u201361.","journal-title":"Neurology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(05)78749-3","article-title":"Association at LRP gene locus with sporadic late-onset Alzheimer\u2019s disease","volume":"351","author":"Lambert, J.C.; Wavrant-DeVrieze, F.; Amouyel, P.","year":"1998","unstructured":"Lambert JC, Wavrant-DeVrieze F, Amouyel P, et al. Association at LRP gene locus with sporadic late-onset Alzheimer\u2019s disease. Lancet 1998;351:1787\u20138.","journal-title":"Lancet"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.1997.03550150041033","article-title":"Complete genomic screen in late-onset familial Alzheimer disease\u2014 evidence for a new locus on chromosome 12","volume":"278","author":"Pericak-Vance, M.A.; Bass, M.P.; Yamaoka, L.H.","year":"1997","unstructured":"Pericak-Vance MA, Bass MP, Yamaoka LH, et al. Complete genomic screen in late-onset familial Alzheimer disease\u2014 evidence for a new locus on chromosome 12. JAMA 1997; 278:1237\u201341.","journal-title":"JAMA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.410370212","article-title":"Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein-E receptor, the alpha(2)-macroglobulin receptor low-density-lipoprotein receptor-related protein","volume":"37","author":"Rebeck, G.W.; Harr, S.D.; Strickland, D.K.","year":"1995","unstructured":"Rebeck GW, Harr SD, Strickland DK, et al. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein-E receptor, the alpha(2)-macroglobulin receptor low-density-lipoprotein receptor-related protein. Ann Neurol 1995;37:211\u201317.","journal-title":"Ann Neurol"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1997.69010299.x","article-title":"Alpha(2)-macroglobulin as a beta-amyloid peptide-binding plasma protein","volume":"69","author":"Du, Y.S.; Ni, B.H.; Glinn, M.","year":"1997","unstructured":"Du YS, Ni BH, Glinn M, et al. Alpha(2)-macroglobulin as a beta-amyloid peptide-binding plasma protein. J Neurochem 1997;69:299\u2013305.","journal-title":"J Neurochem"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1073\/pnas.95.6.3275","article-title":"Alpha(2)macroglobulin associates with beta-amyloid peptide and prevents fibril formation","volume":"95","author":"Hughes, SR, Khorkova; O, Goyal; S.","year":"1998","unstructured":"Hughes SR, Khorkova O, Goyal S, et al. Alpha(2)macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Proc Natl Acad Sci USA 1998;95: 3275\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1046\/j.1471-4159.1998.70031182.x","article-title":"Alpha(2)-macroglobulin attenuates beta-amyloid peptide 1\u201340 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons","volume":"70","author":"Du, Y.S.; Bales, K.R.; Dodel, R.C.","year":"1998","unstructured":"Du YS, Bales KR, Dodel RC, et al. Alpha(2)-macroglobulin attenuates beta-amyloid peptide 1\u201340 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J Neurochem 1998;70:1182\u20138.","journal-title":"J Neurochem"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0092-8674(95)90320-8","article-title":"LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation","volume":"82","author":"Kounnas, M.Z.; Moir, R.D.; Rebeck, G.W.","year":"1995","unstructured":"Kounnas MZ, Moir RD, Rebeck GW, et al. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 1995;82:331\u201340.","journal-title":"Cell"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1093\/nar\/19.18.5102","article-title":"A deletion polymorphism in the human alpha-2-macroglobulin (A2M) gene","volume":"19","author":"Matthijs, G.; Marynen, P.","year":"1991","unstructured":"Matthijs G, Marynen P. A deletion polymorphism in the human alpha-2-macroglobulin (A2M) gene. Nucleic Acids Res 1991;19:5102.","journal-title":"Nucleic Acids Res"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/1243","article-title":"Alpha-2macroglobulin is genetically associated with Alzheimer disease","volume":"19","author":"Blacker, D.; Wilcox, M.A.; Laird, N.M.","year":"1998","unstructured":"Blacker D, Wilcox MA, Laird NM, et al. Alpha-2macroglobulin is genetically associated with Alzheimer disease. Nat Genet 1998;19:357\u201360.","journal-title":"Nat Genet"},{"key":"ref_85","first-page":"619","article-title":"Chromosome-14 and late-onset familial Alzheimer-disease (FAD)","volume":"53","author":"Schellenberg, G.D.; Payami, H.; Wijsman, E.M.","year":"1993","unstructured":"Schellenberg GD, Payami H, Wijsman EM, et al. Chromosome-14 and late-onset familial Alzheimer-disease (FAD). Am J Hum Genet 1993;53:619\u201328.","journal-title":"Am J Hum Genet"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(96)91140-X","article-title":"Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer\u2019s-disease","volume":"347","author":"Wragg, M.; Hutton, M.; Talbot, C.","year":"1996","unstructured":"Wragg M, Hutton M, Talbot C, et al. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer\u2019s-disease. Lancet 1996;347:509\u201312.","journal-title":"Lancet"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0140-6736(96)90643-1","article-title":"Presenilin-1 polymorphism and Alzheimer\u2019s-disease","volume":"347","author":"Kehoe, P.; Williams, J.; Lovestone, S.","year":"1996","unstructured":"Kehoe P, Williams J, Lovestone S, et al. Presenilin-1 polymorphism and Alzheimer\u2019s-disease. Lancet 1996;347: 1185.","journal-title":"Lancet"},{"key":"ref_88","first-page":"1186","article-title":"Presenilin-1 polymorphism and Alzheimer\u2019s-disease","volume":"347","author":"Higuchi, S.; Muramatsu, T.; Matsushita, S.","year":"1996","unstructured":"Higuchi S, Muramatsu T, Matsushita S, et al. Presenilin-1 polymorphism and Alzheimer\u2019s-disease. Lancet 1996;347: 1186.","journal-title":"Lancet"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(96)90716-3","article-title":"Presenilin-1 polymorphism and Alzheimer\u2019s-disease","volume":"347","author":"Scott, W.K.; Roses, A.D.; Haines, J.L.","year":"1996","unstructured":"Scott WK, Roses AD, Haines JL, et al. Presenilin-1 polymorphism and Alzheimer\u2019s-disease. Lancet 1996;347: 1560.","journal-title":"Lancet"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(96)90716-3","article-title":"Presenilin-1 polymorphism and Alzheimer\u2019s-disease","volume":"347","author":"Perez-Tur, J.; Wavrant-DeVrieze, F.; Lambert, J.C.","year":"1996","unstructured":"Perez-Tur J, Wavrant-DeVrieze F, Lambert JC, et al. Presenilin-1 polymorphism and Alzheimer\u2019s-disease. Lancet 1996;347:1560\u20131.","journal-title":"Lancet"},{"key":"ref_91","first-page":"68","article-title":"polymorphism is not associated with autopsy-confirmed late-onset Alzheimer\u2019s disease","volume":"8","author":"Tysoe, C.; Whittaker, J.; Cairns, N.J.","year":"1997","unstructured":"Tysoe C, Whittaker J, Cairns NJ, et al. Presenilin-1 intron 8 polymorphism is not associated with autopsy-confirmed late-onset Alzheimer\u2019s disease. Neurosci Lett 1997;222:68\u2013 9.","journal-title":"Presenilin-1; 9"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1096-8628(19970418)74:2<207::AID-AJMG20>3.0.CO;2-L","article-title":"Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensinconverting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia","volume":"74","author":"Tysoe, C.; Galinsky, D.; Robinson, D.","year":"1997","unstructured":"Tysoe C, Galinsky D, Robinson D, et al. Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensinconverting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia. Am J Med Genet 1997;74:207\u201312.","journal-title":"Am J Med Genet"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","article-title":"Changes in brain cholinesterases in senile dementia of Alzheimer type","volume":"4","author":"Perry, E.K.; Perry, R.H.; Blessed, G.","year":"1978","unstructured":"Perry EK, Perry RH, Blessed G, et al. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol 1978;4:273\u20137.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0006-8993(91)90508-S","article-title":"Electron-microscopic localization of cholinesterase activity in Alzheimer braintissue","volume":"540","author":"Carson, K.A.; Geula, C.; Mesulam, M.M.","year":"1991","unstructured":"Carson KA, Geula C, Mesulam MM. Electron-microscopic localization of cholinesterase activity in Alzheimer braintissue. Brain Res 1991;540:204\u20138.","journal-title":"Brain Res"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ana.410360506","article-title":"Butyrylcholinesterase reactivity diVerentiates the amyloid plaques of aging from those of dementia","volume":"36","author":"Mesulam, M.M.; Geula, C.","year":"1994","unstructured":"Mesulam MM, Geula C. Butyrylcholinesterase reactivity diVerentiates the amyloid plaques of aging from those of dementia. Ann Neurol 1994;36:722\u20137.","journal-title":"Ann Neurol"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-8993(94)91852-X","article-title":"Ultrastructurallocalization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer\u2019sdisease patients","volume":"640","author":"Gomez-Ramos, P.; Bouras, C.; Moran, M.A.","year":"1994","unstructured":"Gomez-Ramos P, Bouras C, Moran MA. Ultrastructurallocalization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer\u2019sdisease patients. Brain Res 1994;640:17\u201324.","journal-title":"Brain Res"},{"key":"ref_97","first-page":"1086","article-title":"DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites","volume":"50","author":"Bartels, C.F.; Jensen, F.S.; Lockridge, O.","year":"1992","unstructured":"Bartels CF, Jensen FS, Lockridge O, et al. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 1992;50:1086\u2013103.","journal-title":"Am J Hum Genet"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/hmg\/6.11.1933","article-title":"Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer\u2019s disease","volume":"6","author":"Lehmann, D.J.; Johnston, C.; Smith, A.D.","year":"1997","unstructured":"Lehmann DJ, Johnston C, Smith AD. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer\u2019s disease. Hum Mol Genet 1997;6:1933\u20136.","journal-title":"Hum Mol Genet"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/hmg\/7.5.933","article-title":"Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease","volume":"7","author":"Brindle, N.; Song, Y.; Rogaeva, E.","year":"1998","unstructured":"Brindle N, Song Y, Rogaeva E, et al. Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease. Hum Mol Genet 1998;7:933\u20135.","journal-title":"Hum Mol Genet"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/hmg\/7.5.937","article-title":"variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer\u2019s disease","volume":"7","author":"Singleton, A.B.; Smith, G.; Gibson, A.M.","year":"1998","unstructured":"Singleton AB, Smith G, Gibson AM, et al. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer\u2019s disease. Hum Mol Genet 1998;7:937\u20139.","journal-title":"Hum Mol Genet"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/372092a0","article-title":"Amyloid-associated proteins alpha(1)-antichymotrypsin and apolipoprotein-E promote assembly of Alzheimer beta-protein into filaments","volume":"372","author":"Ma, J.Y.; Yee, A.; Brewer, H.B.","year":"1994","unstructured":"Ma JY, Yee A, Brewer HB, et al. Amyloid-associated proteins alpha(1)-antichymotrypsin and apolipoprotein-E promote assembly of Alzheimer beta-protein into filaments. Nature 1994;372:92\u20134.","journal-title":"Nature"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02251232","article-title":"Alpha-1antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer\u2019s syndrome","volume":"10","author":"Thome, J.; Baumer, A.; Kornhuber, J.","year":"1995","unstructured":"Thome J, Baumer A, Kornhuber J, et al. Alpha-1antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer\u2019s syndrome. J Neural Transm Park Dis Dement Sect 1995;10:207\u201312.","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ana.410420118","article-title":"Alpha(1)antichymotrypsin as a risk modifier for late-onset Alzheimer\u2019s disease in Japanese apolipoprotein E epsilon 4 allele carriers","volume":"42","author":"Yoshiiwa, A.; Kamino, K.; Yamamoto, H.","year":"1997","unstructured":"Yoshiiwa A, Kamino K, Yamamoto H, et al. Alpha(1)antichymotrypsin as a risk modifier for late-onset Alzheimer\u2019s disease in Japanese apolipoprotein E epsilon 4 allele carriers. Ann Neurol 1997;42:115\u201317.","journal-title":"Ann Neurol"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-8993(97)00330-2","article-title":"Genetic association between susceptibility to Parkinson\u2019s disease and alpha(1)-antichymotrypsin polymorphism","volume":"759","author":"Yamamoto, M.; Kondo, I.; Ogawa, N.","year":"1997","unstructured":"Yamamoto M, Kondo I, Ogawa N, et al. Genetic association between susceptibility to Parkinson\u2019s disease and alpha(1)-antichymotrypsin polymorphism. Brain Res 1997;759:153\u20135.","journal-title":"Brain Res"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ana.410400420","article-title":"Apolipoprotein-E and alpha(1)-antichymotrypsin polymorphism in Alzheimer\u2019s-disease","volume":"40","author":"Nacmias, B.; Tedde, A.; Latorraca, S.","year":"1996","unstructured":"Nacmias B, Tedde A, Latorraca S, et al. Apolipoprotein-E and alpha(1)-antichymotrypsin polymorphism in Alzheimer\u2019s-disease. Ann Neurol 1996;40:678\u201380.","journal-title":"Ann Neurol"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/(SICI)1096-8628(19970418)74:2<192::AID-AJMG15>3.0.CO;2-D","article-title":"No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer\u2019s disease","volume":"74","author":"Fallin, D.; Reading, S.; Schinka, J.","year":"1997","unstructured":"Fallin D, Reading S, Schinka J, et al. No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer\u2019s disease. Am J Med Genet 1997;74:192\u20134.","journal-title":"Am J Med Genet"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jnnp.63.1.103","article-title":"No eVect of the alpha 1-antichymotrypsin A allele in Alzheimer\u2019s disease","volume":"63","author":"Didierjean, O.; Martinez, M.; Campion, D.","year":"1997","unstructured":"Didierjean O, Martinez M, Campion D, et al. No eVect of the alpha 1-antichymotrypsin A allele in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 1997;63:103\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00001756-199601310-00038","article-title":"Polymorphism in AACT gene may lower age-of-onset of Alzheimer\u2019s-disease","volume":"7","author":"Talbot, C.; Houlden, H.; Craddock, N.","year":"1996","unstructured":"Talbot C, Houlden H, Craddock N, et al. Polymorphism in AACT gene may lower age-of-onset of Alzheimer\u2019s-disease. Neuroreport 1996;7:534\u20136.","journal-title":"Neuroreport"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/WNL.48.5.1313","article-title":"No association between the alpha 1-antichymotrypsin A allele and Alzheimer\u2019s disease","volume":"48","author":"Murphy, G.M.; Sullivan, E.V.; Gallagher Thompson, D.","year":"1997","unstructured":"Murphy GM, Sullivan EV, Gallagher Thompson D, et al. No association between the alpha 1-antichymotrypsin A allele and Alzheimer\u2019s disease. Neurology 1997;48:1313\u201316.","journal-title":"Neurology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1749-6632.1996.tb32596.x","article-title":"No association between alpha 1-antichymotrypsin and familial Alzheimer\u2019s disease","volume":"802","author":"Haines, J.L.; Pritchard, M.L.; Saunders, A.M.","year":"1996","unstructured":"Haines JL, Pritchard ML, Saunders AM, et al. No association between alpha 1-antichymotrypsin and familial Alzheimer\u2019s disease. Ann N Y Acad Sci 1996;802:35\u201341.","journal-title":"Ann N Y Acad Sci"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/geno.1996.0158","article-title":"No genetic eVect of alpha(1)-antichymotrypsin in Alzheimer-disease","volume":"33","author":"Haines, J.L.; Pritchard, M.L.; Saunders, A.M.","year":"1996","unstructured":"Haines JL, Pritchard ML, Saunders AM, et al. No genetic eVect of alpha(1)-antichymotrypsin in Alzheimer-disease. Genomics 1996;33:53\u20136.","journal-title":"Genomics"},{"key":"ref_112","first-page":"27","article-title":"Microsatellite polymorphism of the alpha(1)-antichymotrypsin gene locus associated with sporadic Alzheimer\u2019s disease","volume":"99","author":"al","year":"1997","unstructured":"Morgan K, Morgan L, Carpenter K, et al. Microsatellite polymorphism of the alpha(1)-antichymotrypsin gene locus associated with sporadic Alzheimer\u2019s disease. Hum Genet 1997;99:27\u201331.","journal-title":"Hum Genet"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1073\/pnas.94.9.4526","article-title":"Mutations in mitochondrial cytochrome C oxidase genes segregate with lateonset Alzheimer disease","volume":"94","author":"Davis, R.E.; Miller, S.; Herrnstadt, C.","year":"1997","unstructured":"Davis RE, Miller S, Herrnstadt C, et al. Mutations in mitochondrial cytochrome C oxidase genes segregate with lateonset Alzheimer disease. Proc Natl Acad Sci USA 1997;94: 4526\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0006-291X(05)80136-6","article-title":"Detection of point mutations in codon-331 of mitochondrial NADH dehydrogenase subunit-2 in Alzheimer brains","volume":"182","author":"Lin, F.H.; Lin, R.; Wisniewski, H.M.","year":"1992","unstructured":"Lin FH, Lin R, Wisniewski HM, et al. Detection of point mutations in codon-331 of mitochondrial NADH dehydrogenase subunit-2 in Alzheimer brains. Biochem Biophys Res Commun 1992;182:238\u201346.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/bbrc.1997.7793","article-title":"Mitochondrial DNA mutations in Alzheimer\u2019s disease","volume":"241","author":"Hutchin, T.P.; Heath, P.R.; Pearson, R.C.A.","year":"1997","unstructured":"Hutchin TP, Heath PR, Pearson RCA, et al. Mitochondrial DNA mutations in Alzheimer\u2019s disease. Biochem Biophys Res Commun 1997;241:221\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0006-291X(05)80834-4","article-title":"Is a point mutation in the mitochondrial ND2 gene associated with Alzheimer\u2019sdisease","volume":"186","author":"Petruzzella, V.; Chen, X.; Schon, E.A.","year":"1992","unstructured":"Petruzzella V, Chen X, Schon EA. Is a point mutation in the mitochondrial ND2 gene associated with Alzheimer\u2019sdisease. Biochem Biophys Res Commun 1992;186:491\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/geno.1993.1299","article-title":"Mitochondrial-DNA variants observed in Alzheimer-disease and Parkinson disease patients","volume":"17","author":"ShoVner, J.M.; Brown, M.D.; Torroni, A.","year":"1993","unstructured":"ShoVner JM, Brown MD, Torroni A, et al. Mitochondrial-DNA variants observed in Alzheimer-disease and Parkinson disease patients. Genomics 1993;17:171\u201384.","journal-title":"Genomics"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1073\/pnas.92.15.6892","article-title":"A mitochondrial-DNA clone is associated with increased risk for Alzeimer-disease","volume":"92","author":"Hutchin, T.; Cortopassi, G.","year":"1995","unstructured":"Hutchin T, Cortopassi G. A mitochondrial-DNA clone is associated with increased risk for Alzeimer-disease. Proc Natl Acad Sci USA 1995;92:6892\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-3940(95)12146-3","article-title":"No association found between Alzheimer\u2019s-disease and a mitochondrial transfer-RNA glutamine gene variant","author":"Wragg, M.A.; Talbot, C.J.; Morris, J.C.","year":"1995","unstructured":"Wragg MA, Talbot CJ, Morris JC, et al. No association found between Alzheimer\u2019s-disease and a mitochondrial transfer-RNA glutamine gene variant. Neurosci Lett 1995; 201:107\u201310.","journal-title":"Neurosci Lett"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/jmg.33.12.1002","article-title":"The tRNA(Gln) 4336 mitochondrial DNA variant is not a high penetrance mutation which predisposes to dementia before the age of 75 years","volume":"33","author":"Tysoe, C.; Robinson, D.; Brayne, C.","year":"1996","unstructured":"Tysoe C, Robinson D, Brayne C, et al. The tRNA(Gln) 4336 mitochondrial DNA variant is not a high penetrance mutation which predisposes to dementia before the age of 75 years. J Med Genet 1996;33:1002\u20136.","journal-title":"J Med Genet"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1096-8628(19980207)81:1<98::AID-AJMG17>3.0.CO;2-R","article-title":"Initial results of a genome survey for novel Alzheimer\u2019s disease risk genes: association with a locus on the X chromosome","volume":"81","author":"Zubenko, G.S.; StiZer, J.S.; Hughes, H.B.","year":"1998","unstructured":"Zubenko GS, StiZer JS, Hughes HB, et al. Initial results of a genome survey for novel Alzheimer\u2019s disease risk genes: association with a locus on the X chromosome. Am J Med Genet 1998;81:98\u2013107.","journal-title":"Am J Med Genet"},{"key":"ref_122","article-title":"Age influences the synergy between butyrylcholinesterase","volume-title":"4 in late-onset Alzheimer\u2019s disease","author":"Lehmann, D.J.; Johnston, C.; Cortina Borja, M.","year":"1998","unstructured":"Lehmann DJ, Johnston C, Cortina Borja M, et al. Age influences the synergy between butyrylcholinesterase K variant and apolipoprotein E 4 in late-onset Alzheimer\u2019s disease. In: Doctor BP, et al., eds. Structure and function of cholinesterases and related proteins. New York: Plenum Publishing Corporation, 1998. [In press.]"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/brain\/99.3.459","article-title":"Neurotransmitterrelated enzymes and indices of hypoxia in senile dementia and other abiotrophies","volume":"99","author":"Bowen, D.M.; Smith, C.B.; White, P.","year":"1976","unstructured":"Bowen DM, Smith CB, White P, et al. Neurotransmitterrelated enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 1976;99:459\u201396.","journal-title":"Brain"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer\u2019s disease","volume":"ii:","author":"Davies, P.; Maloney, A.J.F.","year":"1976","unstructured":"Davies P, Maloney AJF. Selective loss of central cholinergic neurons in Alzheimer\u2019s disease. Lancet 1976;ii:1403.","journal-title":"Lancet"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(77)91780-9","article-title":"Necropsy evidence of central cholinergic deficits in senile dementia","volume":"i:","author":"Perry, E.K.; Perry, R.H.; Blessed, G.","year":"1977","unstructured":"Perry EK, Perry RH, Blessed G, et al. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1977; i:189.","journal-title":"Lancet"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.3083509","article-title":"A neuronal antigen in the brains of Alzheimer patients","volume":"232","author":"Wolozin, B.L.; Pruchnicki, A.; Dickson, D.W.","year":"1986","unstructured":"Wolozin BL, Pruchnicki A, Dickson DW, et al. A neuronal antigen in the brains of Alzheimer patients. Science 1986;232:648\u201350.","journal-title":"Science"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0304-3940(86)90190-4","article-title":"Excitatory amino acid-releasing and cholinergic neurons in Alzheimer\u2019s-disease","volume":"66","author":"Palmer, A.M.; Procter, A.W.; Stratmann, G.C.","year":"1986","unstructured":"Palmer AM, Procter AW, Stratmann GC, et al. Excitatory amino acid-releasing and cholinergic neurons in Alzheimer\u2019s-disease. Neurosci Lett 1986;66:199\u2013204.","journal-title":"Neurosci Lett"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.410240205","article-title":"Cognitive deficits in olivopontocerebellar atrophy\u2014implications for the cholinergic hypothesis of Alzheimer\u2019s dementia","volume":"24","author":"Kish, S.J.; Elawar, M.; Schut, L.","year":"1988","unstructured":"Kish SJ, Elawar M, Schut L, et al. Cognitive deficits in olivopontocerebellar atrophy\u2014implications for the cholinergic hypothesis of Alzheimer\u2019s dementia. Ann Neurol 1988;24:200\u20136.","journal-title":"Ann Neurol"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s-disease\u2014the amyloid cascade hypothesis","volume":"256","author":"Hardy, J.A.; Higgins, G.A.","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s-disease\u2014the amyloid cascade hypothesis. Science 1992;256:184\u20135.","journal-title":"Science"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.2928783","article-title":"Amyloid-beta protein enhances the survival of hippocampal-neurons in vitro","volume":"243","author":"Whitson, J.S.; Selkoe, D.J.; Cotman, C.W.","year":"1989","unstructured":"Whitson JS, Selkoe DJ, Cotman CW. Amyloid-beta protein enhances the survival of hippocampal-neurons in vitro. Science 1989;243:1488\u201390.","journal-title":"Science"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0304-3940(90)90867-9","article-title":"Beta-amyloid protein promotes neuritic branching in hippocampal cultures","volume":"110","author":"Whitson, J.S.; Glabe, C.G.; Shintani, E.","year":"1990","unstructured":"Whitson JS, Glabe CG, Shintani E, et al. Beta-amyloid protein promotes neuritic branching in hippocampal cultures. Neurosci Lett 1990;110:319\u201324.","journal-title":"Neurosci Lett"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1126\/science.2474201","article-title":"Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer\u2019s-disease","volume":"245","author":"Yankner, B.A.; Dawes, L.R.; Fisher, S.","year":"1989","unstructured":"Yankner BA, Dawes LR, Fisher S, et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer\u2019s-disease. Science 1989;245:417\u201320.","journal-title":"Science"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.2218531","article-title":"Neurotrophic and neurotoxic eVects of amyloid beta-protein\u2014reversal by tachykinin neuropeptides","volume":"250","author":"Yankner, B.A.; DuVy, L.K.; Kirschner, D.A.","year":"1990","unstructured":"Yankner BA, DuVy LK, Kirschner DA. Neurotrophic and neurotoxic eVects of amyloid beta-protein\u2014reversal by tachykinin neuropeptides. Science 1990;250:279\u201382.","journal-title":"Science"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-8993(91)91553-D","article-title":"In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity","volume":"563","author":"Pike, C.J.; Walencewicz, A.J.; Glabe, C.G.","year":"1991","unstructured":"Pike CJ, Walencewicz AJ, Glabe CG, et al. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 1991;563:311\u201314.","journal-title":"Brain Res"},{"key":"ref_135","first-page":"163","article-title":"Attenuation of the neurotoxic eVect of a-beta amyloid peptide by apolipoprotein-E","author":"Whitson, J.S.; Mims, M.P.; Strittmatter, W.J.","year":"1994","unstructured":"Whitson JS, Mims MP, Strittmatter WJ, et al. Attenuation of the neurotoxic eVect of a-beta amyloid peptide by apolipoprotein-E. Biochem Biophys Res Commun 1994;199: 163\u201370.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3940(96)13082-2","article-title":"Alpha-1antichymotrypsin interaction with a-beta(1\u201342) does not inhibit fibril formation but attenuates the peptide toxicity","volume":"217","author":"Aksenov, M.Y.; Aksenova, M.V.; Carney, J.M.","year":"1996","unstructured":"Aksenov MY, Aksenova MV, Carney JM, et al. Alpha-1antichymotrypsin interaction with a-beta(1\u201342) does not inhibit fibril formation but attenuates the peptide toxicity. Neurosci Lett 1996;217:117\u201320.","journal-title":"Neurosci Lett"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0006-8993(90)91355-K","article-title":"Beta-amyloid protein increases the vulnerability of cultured cortical-neurons to excitotoxic damage","volume":"533","author":"Koh, J.Y.; Yang, L.L.; Cotman, C.W.","year":"1990","unstructured":"Koh JY, Yang LL, Cotman CW. Beta-amyloid protein increases the vulnerability of cultured cortical-neurons to excitotoxic damage. Brain Res 1990;533:315\u201320.","journal-title":"Brain Res"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"17577","DOI":"10.1016\/S0021-9258(18)45420-8","article-title":"Phosphorylation of tau-proteins to a state like that in Alzheimer\u2019s brain is catalyzed by a calcium calmodulin-dependent kinase and modulated by phospholipids","volume":"262","author":"Baudier, J.; Cole, R.D.","year":"1987","unstructured":"Baudier J, Cole RD. Phosphorylation of tau-proteins to a state like that in Alzheimer\u2019s brain is catalyzed by a calcium calmodulin-dependent kinase and modulated by phospholipids. J Biol Chem 1987;262:17577\u201383.","journal-title":"J Biol Chem"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3940(96)12668-9","article-title":"Age, neurofibrillary changes, a-beta-amyloid and the onset of Alzheimer\u2019sdisease","volume":"210","author":"Braak, H.; Braak, E.; Bohl, J.","year":"1996","unstructured":"Braak H, Braak E, Bohl J, et al. Age, neurofibrillary changes, a-beta-amyloid and the onset of Alzheimer\u2019sdisease. Neurosci Lett 1996;210:87\u201390.","journal-title":"Neurosci Lett"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1091\/mbc.3.10.1141","article-title":"Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau","volume":"3","author":"Drechsel, D.N.; Hyman, A.A.; Cobb, M.H.","year":"1992","unstructured":"Drechsel DN, Hyman AA, Cobb MH, et al. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell 1992;3: 1141\u201354.","journal-title":"Mol Biol Cell"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00005072-199655100-00001","article-title":"The pathogenesis of Alzheimer-disease\u2014an alternative to the amyloid hypothesis","volume":"55","author":"Terry, R.D.","year":"1996","unstructured":"Terry RD. The pathogenesis of Alzheimer-disease\u2014an alternative to the amyloid hypothesis. J Neuropathol Exp Neurol 1996;55:1023\u20135.","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0197-4580(90)90885-4","article-title":"CSF alpha-1antichymotrypsin level is elevated in patients with Alzheimer-type dementia","volume":"11","author":"Matsubara, E.; Amari, M.; Shoji, M.","year":"1990","unstructured":"Matsubara E, Amari M, Shoji M, et al. CSF alpha-1antichymotrypsin level is elevated in patients with Alzheimer-type dementia. Neurobiol Aging 1990;11:333.","journal-title":"Neurobiol Aging"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0304-3940(91)90490-K","article-title":"Elevated circulating tumornecrosis-factor levels in Alzheimer\u2019s-disease","volume":"129","author":"Fillit, H.; Ding, W.; Buee, L.","year":"1991","unstructured":"Fillit H, Ding W, Buee L, et al. Elevated circulating tumornecrosis-factor levels in Alzheimer\u2019s-disease. Neurosci Lett 1991;129:318\u201320.","journal-title":"Neurosci Lett"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0923-2494(92)80044-L","article-title":"Distribution pattern and functional-state of complement proteins and alpha-1-antichymotrypsin in cerebral beta\/A4 deposits in Alzheimer\u2019s-disease","volume":"143","author":"Eikelenboom, P.; Hack, C.E.; Kamphorst, W.","year":"1992","unstructured":"Eikelenboom P, Hack CE, Kamphorst W, et al. Distribution pattern and functional-state of complement proteins and alpha-1-antichymotrypsin in cerebral beta\/A4 deposits in Alzheimer\u2019s-disease. Res Immunol 1992;143:617\u201320.","journal-title":"Res Immunol"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.4049\/jimmunol.146.9.3032","article-title":"EVects of cytokine combinations on acute phase protein production in two human hepatoma cell lines","volume":"146","author":"Mackiewicz, A.; SperoV, T.; Ganapathi, M.K.","year":"1991","unstructured":"Mackiewicz A, SperoV T, Ganapathi MK, et al. EVects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 1991;146: 3032\u20137.","journal-title":"J Immunol"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1074\/jbc.273.7.4112","article-title":"the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha(1)-antichymotrypsin expression in human cortical astrocytes","volume":"273","author":"Kordula, T.; Rydel, R.E.; Brigham, E.F.","year":"1998","unstructured":"Kordula T, Rydel RE, Brigham EF, et al. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha(1)-antichymotrypsin expression in human cortical astrocytes. J Biol Chem 1998;273:4112\u201318.","journal-title":"J Biol Chem"},{"key":"ref_147","first-page":"7606","article-title":"Interleukin-1 regulates synthesis of amyloid beta-protein precursor messenger-RNA","volume-title":"human-endothelial cells. Proc Natl Acad Sci","volume":"86","author":"Goldgaber, D.; Harris, H.W.; Hla, T.","year":"1989","unstructured":"Goldgaber D, Harris HW, Hla T, et al. Interleukin-1 regulates synthesis of amyloid beta-protein precursor messenger-RNA in human-endothelial cells. Proc Natl Acad Sci USA 1989;86:7606\u201310."},{"key":"ref_148","first-page":"7611","article-title":"Brain interleukin-1 and S-100 immunoreactivity are elevated in Down","volume-title":"syndrome and Alzheimer-disease. Proc Natl Acad Sci","volume":"86","author":"GriYn, W.S.T.; Stanley, L.C.; Ling, C.","year":"1989","unstructured":"GriYn WST, Stanley LC, Ling C, et al. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer-disease. Proc Natl Acad Sci USA 1989;86:7611\u201315."},{"key":"ref_149","first-page":"621","article-title":"Immunohistochemical evidence of antioxidant stress in Alzheimer\u2019sdisease","volume":"140","author":"Pappolla, M.A.; Omar, R.A.; Kim, K.S.","year":"1992","unstructured":"Pappolla MA, Omar RA, Kim KS, et al. Immunohistochemical evidence of antioxidant stress in Alzheimer\u2019sdisease. Am J Pathol 1992;140:621\u20138.","journal-title":"Am J Pathol"},{"key":"ref_150","first-page":"42","article-title":"Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer\u2019s-disease","volume":"145","author":"Smith, M.A.; Kutty, R.K.; Richey, P.L.","year":"1994","unstructured":"Smith MA, Kutty RK, Richey PL, et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer\u2019s-disease. Am J Pathol 1994;145:42\u20137.","journal-title":"Am J Pathol"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(94)90131-7","article-title":"Hydrogen-peroxide mediates amyloid-beta protein toxicity","volume":"77","author":"Behl, C.; Davis, J.B.; Lesley, R.","year":"1994","unstructured":"Behl C, Davis JB, Lesley R, et al. Hydrogen-peroxide mediates amyloid-beta protein toxicity. Cell 1994;77:817\u2013 27.","journal-title":"Cell"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"13623","DOI":"10.1016\/S0021-9258(17)36875-8","article-title":"Inhibition of energy-metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative","volume":"269","author":"Gabuzda, D.; Busciglio, J.; Chen, L.B.","year":"1994","unstructured":"Gabuzda D, Busciglio J, Chen LB, et al. Inhibition of energy-metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 1994;269:13623\u20138.","journal-title":"J Biol Chem"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.1998.70010001.x","article-title":"Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer\u2019s disease","volume":"70","author":"Mattson, M.P.; Guo, Q.; Furukawa, K.","year":"1998","unstructured":"Mattson MP, Guo Q, Furukawa K, et al. Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer\u2019s disease. J Neurochem 1998;70:1\u201314.","journal-title":"J Neurochem"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1523\/JNEUROSCI.17-11-04212.1997","article-title":"Alzheimer\u2019s presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals","volume":"17","author":"Guo, Q.; Sopher, B.L.; Furukawa, K.","year":"1997","unstructured":"Guo Q, Sopher BL, Furukawa K, et al. Alzheimer\u2019s presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J Neurosci 1997;17:4212\u201322.","journal-title":"J Neurosci"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(89)92143-0","article-title":"Decline in skeletal-muscle mitochondrial respiratory-chain function\u2014possible factor in aging","volume":"1","author":"Trounce, I.; Byrne, E.; Marzuki, S.","year":"1989","unstructured":"Trounce I, Byrne E, Marzuki S. Decline in skeletal-muscle mitochondrial respiratory-chain function\u2014possible factor in aging. Lancet 1989;1:637\u20139.","journal-title":"Lancet"},{"key":"ref_156","first-page":"1167","article-title":"Cytochrome-C-oxidase deficient cardiomyocytes in the human heart\u2014an age-related phenomenon\u2014a histochemical ultracytochemical study","volume":"134","author":"Mullerhocker, J.","year":"1989","unstructured":"Mullerhocker J. Cytochrome-C-oxidase deficient cardiomyocytes in the human heart\u2014an age-related phenomenon\u2014a histochemical ultracytochemical study. Am J Pathol 1989;134:1167\u201373.","journal-title":"Am J Pathol"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0006-291X(89)92701-0","article-title":"Liver mitochondrial respiratory functions decline with age","volume":"165","author":"Yen, T.C.; Chen, Y.S.; King, K.L.","year":"1989","unstructured":"Yen TC, Chen YS, King KL, et al. Liver mitochondrial respiratory functions decline with age. Biochem Biophys Res Commun 1989;165:994\u20131003.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ana.410210507","article-title":"Altered metabolic properties of cultured skin fibroblasts in Alzheimer\u2019s-disease","volume":"21","author":"Sims, N.R.; Finegan, J.M.; Blass, J.P.","year":"1987","unstructured":"Sims NR, Finegan JM, Blass JP. Altered metabolic properties of cultured skin fibroblasts in Alzheimer\u2019s-disease. Ann Neurol 1987;21:451\u20137.","journal-title":"Ann Neurol"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.40.8.1302","article-title":"Cytochrome-oxidase deficiency in Alzheimer\u2019s-disease","volume":"40","author":"Parker, W.D.; Filley, C.M.; Parks, J.K.","year":"1990","unstructured":"Parker WD, Filley CM, Parks JK. Cytochrome-oxidase deficiency in Alzheimer\u2019s-disease. Neurology 1990;40:1302\u20133.","journal-title":"Neurology"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00001756-199305000-00015","article-title":"Apoptosis mediated neurotoxicity induced by chronic application of betaamyloid fragment 25\u201335","volume":"4","author":"Forloni, G.; Chiesa, R.; Smiroldo, S.","year":"1993","unstructured":"Forloni G, Chiesa R, Smiroldo S, et al. Apoptosis mediated neurotoxicity induced by chronic application of betaamyloid fragment 25\u201335. Neuroreport 1993;4:523\u20136.","journal-title":"Neuroreport"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/j.1460-2075.1996.tb00382.x","article-title":"Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype","volume":"15","author":"Yamatsuji, T.; Okamoto, T.; Takeda, S.","year":"1996","unstructured":"Yamatsuji T, Okamoto T, Takeda S, et al. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype. EMBO J 1996;15:498\u2013509.","journal-title":"EMBO J"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1126\/science.274.5293.1710","article-title":"Participation of presenilin-2 in apoptosis\u2014enhanced basal activity conferred by an Alzheimer mutation","volume":"274","author":"Wolozin, B.; Iwasaki, K.; Vito, P.","year":"1996","unstructured":"Wolozin B, Iwasaki K, Vito P, et al. Participation of presenilin-2 in apoptosis\u2014enhanced basal activity conferred by an Alzheimer mutation. Science 1996;274:1710\u201313.","journal-title":"Science"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1523\/JNEUROSCI.16-23-07533.1996","article-title":"Amyloid beta peptide of Alzheimer\u2019s disease downregulates bcl-2 and upregulates bax expression in human neurons","volume":"16","author":"Paradis, E.; Douillard, H.; Koutroumanis, M.","year":"1996","unstructured":"Paradis E, Douillard H, Koutroumanis M, et al. Amyloid beta peptide of Alzheimer\u2019s disease downregulates bcl-2 and upregulates bax expression in human neurons. J Neurosci 1996;16:7533\u20139.","journal-title":"J Neurosci"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00005072-199701000-00009","article-title":"Bax protein expression is increased in Alzheimer\u2019s brain: correlations with DNA damage, Bcl-2 expression, and brain pathology","volume":"56","author":"Su, J.H.; Deng, G.M.; Cotman, C.W.","year":"1997","unstructured":"Su JH, Deng GM, Cotman CW. Bax protein expression is increased in Alzheimer\u2019s brain: correlations with DNA damage, Bcl-2 expression, and brain pathology. J Neuropathol Exp Neurol 1997;56:86\u201393.","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00001756-199505090-00026","article-title":"In-situ evidence for DNA fragmentation in Huntington\u2019s-disease striatum and Alzheimer\u2019s-disease temporal lobes","volume":"6","author":"Dragunow, M.; Faull, R.L.M.; Lawlor, P.","year":"1995","unstructured":"Dragunow M, Faull RLM, Lawlor P, et al. In-situ evidence for DNA fragmentation in Huntington\u2019s-disease striatum and Alzheimer\u2019s-disease temporal lobes. Neuroreport 1995; 6:1053\u20137.","journal-title":"Neuroreport"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00294257","article-title":"Cell-death in Alzheimer\u2019s-disease evaluated by DNA fragmentation in-situ","volume":"89","author":"Lassmann, H.; Bancher, C.; Breitschopf, H.","year":"1995","unstructured":"Lassmann H, Bancher C, Breitschopf H, et al. Cell-death in Alzheimer\u2019s-disease evaluated by DNA fragmentation in-situ. Acta Neuropathol 1995;89:35\u201341.","journal-title":"Acta Neuropathol"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00005072-199708000-00007","article-title":"DNA damage distribution in the human brain as shown by in situ end labeling; area-specific diVerences in aging and Alzheimer disease in the absence of apoptotic morphology","volume":"56","author":"Lucassen, P.J.; Chung, W.C.J.; Kamphorst, W.","year":"1997","unstructured":"Lucassen PJ, Chung WCJ, Kamphorst W, et al. DNA damage distribution in the human brain as shown by in situ end labeling; area-specific diVerences in aging and Alzheimer disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol 1997;56:887\u2013900.","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/exnr.1995.1025","article-title":"Evidence for apoptotic cell-death in Alzheimer\u2019s-disease","volume":"133","author":"true","year":"1995","unstructured":"Smale G, Nichols NR, Brady DR, et al. Evidence for apoptotic cell-death in Alzheimer\u2019s-disease. Exp Neurol 1995; 133:225\u201330.","journal-title":"Exp Neurol"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00005072-199805000-00009","article-title":"Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis","volume":"57","author":"Stadelmann, C.; Bruck, W.; Bancher, C.","year":"1998","unstructured":"Stadelmann C, Bruck W, Bancher C, et al. Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol 1998;57:456\u201364.","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.279.5348.242","article-title":"Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer\u2019s and Down patients","volume":"279","author":"FW, Van Leeuwen; deKleijn DPV; vandenHurk HH","year":"1998","unstructured":"Van Leeuwen FW, deKleijn DPV, vandenHurk HH, et al. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer\u2019s and Down patients. Science 1998;279:242\u20137.","journal-title":"Science"},{"key":"ref_171","first-page":"19","article-title":"Recent progress on the biologic and clinicalsignificance of advanced glycosylation end-products","volume":"124","author":"Vlassara, H.","year":"1994","unstructured":"Vlassara H. Recent progress on the biologic and clinicalsignificance of advanced glycosylation end-products. J Lab Clin Med 1994;124:19\u201330.","journal-title":"J Lab Clin Med"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1073\/pnas.93.9.3902","article-title":"Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine","volume":"93","author":"Li, Y.M.; SteVes, M.; Donnelly, T.","year":"1996","unstructured":"Li YM, SteVes M, Donnelly T, et al. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc Natl Acad Sci USA 1996;93:3902\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_173","first-page":"4766","article-title":"Advanced glycation end-products contribute to","volume-title":"amyloidosis in Alzheimer-disease. Proc Natl Acad Sci USA","volume":"91","author":"Vitek, M.P.; Bhattacharya, K.; Glendening, J.M.","year":"1994","unstructured":"Vitek MP, Bhattacharya K, Glendening JM, et al. Advanced glycation end-products contribute to amyloidosis in Alzheimer-disease. Proc Natl Acad Sci USA 1994;91: 4766\u201370."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(97)00266-8","article-title":"Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer\u2019s disease","volume":"226","author":"Li, Y.M.; Dickson, D.W.","year":"1997","unstructured":"Li YM, Dickson DW. Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer\u2019s disease. Neurosci Lett 1997;226:155\u20138.","journal-title":"Neurosci Lett"}],"container-title":["Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/mp.51.6.293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T17:50:28Z","timestamp":1756057828000},"score":1,"resource":{"primary":{"URL":"https:\/\/mp.bmj.com\/lookup\/doi\/10.1136\/mp.51.6.293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":174,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1998,12,1]]},"published-print":{"date-parts":[[1998,12]]}},"alternative-id":["10.1136\/mp.51.6.293"],"URL":"https:\/\/doi.org\/10.1136\/mp.51.6.293","relation":{},"ISSN":["1366-8714","1472-4154"],"issn-type":[{"value":"1366-8714","type":"print"},{"value":"1472-4154","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}